Shares Outstanding
Total shares outstanding over time.
Latest Shares Outstanding: $945,383,757.00 (2025Q3); -0.4% YoY; -1.2% CAGR since 2009Q2 (16.25y).
Chart and table show the latest 24 of 50 quarters.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly Shares Outstanding Data
Chart and table show the latest 24 of 50 quarters.
| Period | Value |
|---|---|
| 2018Q1 | $1,085,430,420.00 |
| 2018Q2 | $1,073,987,856.00 |
| 2018Q3 | $1,059,322,255.00 |
| 2019Q1 | $970,830,868.00 |
| 2019Q2 | $965,432,952.00 |
| 2019Q3 | $960,130,771.00 |
| 2020Q1 | $956,450,448.00 |
| 2020Q2 | $956,470,372.00 |
| 2020Q3 | $956,581,598.00 |
| 2021Q1 | $959,025,446.00 |
| 2021Q2 | $956,580,893.00 |
| 2021Q3 | $956,592,393.00 |
| 2022Q1 | $950,159,559.00 |
| 2022Q2 | $950,174,817.00 |
| 2022Q3 | $950,177,900.00 |
| 2023Q1 | $949,272,933.00 |
| 2023Q2 | $949,295,173.00 |
| 2023Q3 | $949,307,237.00 |
| 2024Q1 | $950,405,386.00 |
| 2024Q2 | $950,425,778.00 |
| 2024Q3 | $949,315,694.00 |
| 2025Q1 | $947,735,651.00 |
| 2025Q2 | $946,456,759.00 |
| 2025Q3 | $945,383,757.00 |
Healthcare Comparison
1 / 3
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 8